Literature DB >> 29997030

Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.

Susan Maria1, Gaurav Barnwal2, Anil Kumar3, Karthika Mohan1, Vivek Vinod2, Aswathi Varghese1, Raja Biswas2.   

Abstract

BACKGROUND: Candida parapsilosis is recognized as a species complex: Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis are three distinct but closely related species. AIMS: To determine the species and antifungal susceptibility of members of the C. parapsilosis complex, isolated from clinical samples.
METHODS: Isolates identified as C. parapsilosis complex by VITEK® 2 system were included. Antifungal susceptibility test was done using the VITEK® 2 semi-automated system. The distribution of the species in the complex was determined by multiplex PCR.
RESULTS: Among the seventy-seven C. parapsilosis complex isolates, C. parapsilosis sensu stricto (57.1%) was the commonest species, followed by C. orthopsilosis (40.2%) and C. metapsilosis (2.5%). All three species were susceptible to amphotericin B, caspofungin and micafungin. Among C. parapsilosis sensu stricto isolates, 16% were resistant to fluconazole while 2.2% showed dose dependent susceptibility. Also, 18.2% of C. parapsilosis sensu stricto isolates showed dose dependent susceptibility to voriconazole.
CONCLUSIONS: C. parapsilosis sensu stricto was the most commonly isolated member of the C. parapsilosis complex and it showed high resistance to fluconazole. A high prevalence of C. orthopsilosis (40.2%) was also noted.
Copyright © 2018 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Candida metapsilosis; Candida orthopsilosis; Fluconazol; Fluconazole; Polymerase chain reaction; Reacción en cadena de la polimerasa

Mesh:

Substances:

Year:  2018        PMID: 29997030     DOI: 10.1016/j.riam.2018.01.004

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  4 in total

1.  Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital.

Authors:  Yan-Jun Zheng; Ting Xie; Er-Zhen Chen; Zhi-Tao Yang; Lin Wu; Xiao-Ying Liu; Ling Zhu; Ying Chen; En-Qiang Mao; Li-Zhong Han
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-13       Impact factor: 3.944

2.  Antifungal susceptibility pattern and biofilm-related genes expression in planktonic and biofilm cells of Candida parapsilosis species complex.

Authors:  Mona Modiri; Seyed Jamal Hashemi; Roshanak Daie GhazvinI; Sadegh Khodavaisy; Ali Ahmadi; Mansoureh Ghaffari; Sassan Rezaie
Journal:  Curr Med Mycol       Date:  2019

Review 3.  Global Prevalence of Antifungal-Resistant Candida parapsilosis: A Systematic Review and Meta-Analysis.

Authors:  Dina Yamin; Mutiat Hammed Akanmu; Abbas Al Mutair; Saad Alhumaid; Ali A Rabaan; Khalid Hajissa
Journal:  Trop Med Infect Dis       Date:  2022-08-16

4.  Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A.

Authors:  Rong Cheng; Wei Li; Klarke M Sample; Qiang Xu; Lin Liu; Fuxun Yu; Yingjie Nie; Xiangyan Zhang; Zhenhua Luo
Journal:  PeerJ       Date:  2020-09-07       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.